"SK bioscience begins international Phase I/II trial for GBP511 vaccine" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus FamilyNext-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle ...

The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...

The administration of vaccination in Australia allows all adults who have not been infected with the virus or received a booster within the past six months to get an additional dose.

Adrian Esterman receives funding from the NHMRC, MRFF and ARC. COVID rarely rates a mention in the news these days, yet it hasn’t gone away. SARS-CoV-2, the virus that causes COVID, is still with us.

If we want to lift childhood vaccination rates again, we need to acknowledge that shadow, rebuild trust carefully, and ...